1 Min Read
Feb 5 (Reuters) - Novo Nordisk A/S:
* NOVO NORDISK - ANNOUNCED AVAILABILITY OF NEW DIABETES MEDICATIONS, OZEMPIC INJECTION 0.5 MG OR 1 MG AND FIASP 100 UNITS/ML AT PHARMACIES ACROSS U.S. Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.